Michael Buck's lab at the University of Buffalo studies how transcription factors (TFs) interact with DNA in our cells. They focus on understanding the rules that govern how these proteins bind to chromatin, which is the material that makes up our chromosomes, particularly when it is tightly packed. By exploring these interactions, the lab seeks to uncover insights into gene expression, which is crucial for normal development and understanding diseases.

Stephen Buratowski's lab at Harvard Medical School focuses on understanding the intricate processes of gene expression by examining how RNA polymerase II, an enzyme responsible for transcribing DNA into RNA, is regulated. The lab investigates the role of various protein modifications and interactions during transcription, which has significant implications for diseases such as cancer and viral infections like HIV. By utilizing cutting-edge techniques like mass spectrometry and single-molecule microscopy, they aim to uncover dynamic events that govern gene expression, potentially leading to new therapeutic strategies.

Dr. Peter M. Burgers' lab focuses on understanding how DNA replication works in cells and what happens when this process goes wrong. They use yeast as a model organism to investigate the mechanisms behind DNA replication, the consequences of errors in this process, and how cells respond to such errors. The aim is to uncover the intricate details of these pathways which are essential for maintaining genetic integrity and preventing diseases like cancer.

Dr. Samuel E. Butcher's lab at the University of Wisconsin-Madison focuses on understanding how RNA-protein complexes regulate gene expression and their implications for genetic disorders. Using a variety of biophysical methods, the research explores the structural dynamics of essential RNA components like the spliceosome and the role of newly discovered RNA types involved in gene silencing. This work aims to uncover the molecular mechanisms underlying these interactions and their connection to diseases such as Alzheimer's and ALS.

David D. Thomas's lab at the University of Minnesota focuses on developing new drugs to treat skeletal muscle disorders by targeting the regulation of calcium within muscle cells. The team uses innovative fluorescent biosensors to identify small molecules that can correct dysfunctional calcium channels and pumps in muscle tissue. Their research aims to improve therapies for myopathies and other related diseases.

Dr. Jin Wang's lab focuses on developing new cancer treatments by targeting specific proteins in cells. The team studies how these proteins influence immune responses in cancer therapy, particularly in the context of experimental treatments that could make current therapies more effective. By investigating the role of RIPK1 — a protein that affects cell survival and immune signaling — they aim to create new drugs that help patients who do not respond to existing cancer immunotherapies.

Dr. Kent E. Vrana's lab is focused on understanding how cannabis extracts may help relieve chronic pain. By using advanced AI techniques, the lab aims to map out the interactions of various cannabis compounds with biological targets to uncover their therapeutic potential. The research combines computer modeling with laboratory experiments, seeking to validate the effectiveness of these natural products in pain management.

Dr. Gucan Dai's research lab focuses on understanding how specific ion channels in the heart respond to electrical signals, which is crucial for understanding heart conditions like arrhythmias. The lab employs advanced techniques to investigate the structural changes in these channels that occur during their activation, as well as how mutations can impact their function. This research could lead to new treatments for heart diseases by identifying potential therapeutic targets in heart channel mechanisms.

Dr. Benjamin A Garcia's lab at Washington University focuses on understanding complex biological processes related to cardiovascular health and neurological development using cutting-edge chemical biology approaches. The lab investigates the role of specific protein modifications in heart development and disease, as well as how epigenetic mechanisms influence neurological disorders. By employing advanced mass spectrometry and innovative research techniques, they aim to uncover new therapeutic strategies and improve our understanding of critical cellular functions.

Richard W. Carthew's lab at Northwestern University studies gene regulation in developmental biology, primarily using the fruit fly Drosophila as a model organism. The research focuses on understanding the roles of non-coding RNAs, particularly long non-coding RNAs, in gene regulation and cell fate during development. Additionally, the lab investigates how external signals and tissue morphology influence cellular processes and development, utilizing advanced mathematical models and experimental techniques.

Dr. Pau Castel's lab focuses on understanding rare neurogenetic disorders and their associated molecular mechanisms, particularly Schwannomatosis, which involves the growth of nerve tumors. The research aims to identify how genetic mutations affect Schwann cells and contribute to tumor formation, and to explore potential treatments. The lab also studies the roles of non-classical RAS oncoproteins in cancer, looking for new ways to target these molecules for better cancer therapies.

The Cate lab at UC Berkeley studies how protein synthesis, or translation, is regulated in humans. They focus on a special protein called eIF3 that controls how and when specific messenger RNAs are translated into proteins. This research is important because it can lead to new methods for treating diseases by better understanding translation control and developing new drugs targeting difficult-to-target proteins.

Dr. Mark C Hall's research lab at Purdue University focuses on understanding how a specific protein, Cdc14 phosphatase, affects the virulence and drug resistance of fungal pathogens, particularly Candida species. The lab explores how this protein influences cell wall integrity, fungal growth, and responses to antifungal drugs, with the aim of identifying new targets for antifungal therapies. By studying the molecular mechanisms behind Cdc14's role, the lab seeks to contribute to the development of effective treatments for life-threatening fungal infections, especially in immune-compromised patients.

Dr. Bruce Bowerman’s lab at the University of Oregon focuses on studying how cells divide, particularly in the early embryos of a small worm called C. elegans. By using advanced techniques like live cell imaging and CRISPR technology, the lab investigates the role of the cytoskeleton during cell division, which has implications for understanding fertility and cancer. This research helps to uncover general principles of how cells function in all animals.

Dr. Michelle Chan's lab at Princeton University is focused on understanding how mammalian cells differentiate from pluripotent stem cells into specific cell types, like neurons or muscle. By creating comprehensive cell fate maps, her team aims to reveal the intricate pathways of differentiation, which might lead to advancements in cellular therapies for diseases such as Parkinson's and diabetes. The lab primarily employs innovative techniques like CRISPR genome editing and single-cell RNA sequencing to trace cell lineages and analyze the data computationally.

The Rhind lab at the University of Massachusetts Medical School focuses on understanding how cells control their growth and division, particularly in the context of size homeostasis and DNA replication. They explore questions such as how cells decide when to divide and how they manage the timing of DNA replication, which are critical for maintaining genome stability and preventing diseases like cancer. Using model organisms like fission yeast, the lab aims to unravel the mechanisms behind these essential cellular processes, which have implications for understanding human health and disease.

Dr. James B Moseley's lab at Dartmouth College studies how cells control their size and shape, focusing on basic cellular mechanisms that can contribute to diseases like cancer. By using fission yeast as a model organism, the lab explores the processes involved in cell growth and division. Their interdisciplinary approach combines genetics and various microscopy techniques to uncover important signals that regulate these fundamental biological functions.

Dr. Douglas R. Kellogg's lab at UC Santa Cruz focuses on understanding how cells control their growth and size, fundamental processes that are crucial for healthy cell function. They explore the signals and mechanisms that link growth to cell cycle progression, particularly through a network known as TORC2. By studying these processes in yeast, the lab aims to uncover insights that could impact our understanding of cancer growth and offer pathways for new treatments.

Dr. Rajat Rohatgi's lab at Stanford University focuses on understanding how cells communicate with each other during development and disease. His team investigates key signaling pathways, specifically the Hedgehog and WNT pathways, which are crucial for tissue formation and maintenance. By uncovering how these signals are transmitted within cells, the lab aims to develop new strategies to address diseases such as cancer and congenital disorders.

Dr. Martin Graef's lab at Cornell University studies how cellular aging works, particularly through the lens of autophagy, a process where cells clean out damaged components. Using yeast as a model organism, the lab investigates how different forms of autophagy can affect lifespan and aging. The goal is to uncover new biological mechanisms that could help improve health as we age and might one day inform therapies for age-related diseases.